PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-305.00%
Both yoy net incomes decline, with CRK at -3242.40%. Martin Whitman would view it as a broader sector or cyclical slump hitting profits.
1.03%
D&A growth of 1.03% while CRK is zero at 0.00%. Bruce Berkowitz would see a mild cost difference that must be justified by expansions.
-245.73%
Both lines show negative yoy. Martin Whitman would see an industry or cyclical factor reducing tax deferrals for both players.
No Data
No Data available this quarter, please select a different quarter.
-25.56%
Both reduce yoy usage, with CRK at -181.18%. Martin Whitman would find an industry or cyclical factor prompting leaner operational approaches.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-25.56%
Both reduce yoy usage, with CRK at -159.21%. Martin Whitman would suspect an industry or cyclical factor pulling back on these items.
10.26%
Lower 'other non-cash' growth vs. CRK's 79.64%, indicating steadier reported figures. David Dodd would confirm no missed necessary write-downs or gains.
-16.98%
Both yoy CFO lines are negative, with CRK at -32.41%. Martin Whitman would suspect cyclical or cost factors harming the entire niche’s cash generation.
16.40%
Some CapEx rise while CRK is negative at -228.40%. John Neff would see competitor possibly building capacity while we hold back expansions.
38350.00%
Acquisition growth of 38350.00% while CRK is zero at 0.00%. Bruce Berkowitz sees a mild outflow that must deliver synergy to justify the difference.
100.00%
Purchases growth of 100.00% while CRK is zero at 0.00%. Bruce Berkowitz sees a mild difference in portfolio building that might matter for returns.
-100.00%
We reduce yoy sales while CRK is 0.00%. Joel Greenblatt sees competitor possibly capitalizing on market peaks or forced to raise cash while we hold tight.
61.77%
Growth well above CRK's 26.57%. Michael Burry would suspect heavier intangible or side spending overshadowing competitor’s approach, risking short-term FCF.
106.38%
We have mild expansions while CRK is negative at -232.90%. John Neff sees competitor possibly divesting or pausing expansions more aggressively.
6.98%
Debt repayment growth of 6.98% while CRK is zero at 0.00%. Bruce Berkowitz sees a mild advantage that can reduce interest costs unless expansions demand capital here.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.